Ultrasound versus Conventional Treat-To-Target Strategies in Early Rheumatoid Arthritis: Magnetic Resonance Imaging Outcome Data from a 2-year Randomized Controlled Strategy Trial

被引：0
|
作者：
Sundin, Ulf [1 ,2 ]
Aga, Anna-Birgitte [1 ]
Skare, Oivind [1 ]
Nordberg, Lena [1 ]
Uhlig, Till [3 ]
Hammer, Hilde [1 ]
van der Heijde, Desiree [4 ]
Kvien, Tore [3 ]
Lillegraven, Siri [1 ]
Haavardsholm, Espen [3 ]
机构：
[1] Diakonhjemmet Hosp, Dept Rheumatol, Oslo, Norway
[2] Univ Oslo, Oslo, Norway
[3] Univ Oslo, Diakonhjemmet Hosp, Dept Rheumatol, Fac Med, Oslo, Norway
[4] Leiden Univ, Med Ctr, Leiden, Netherlands
来源：
ARTHRITIS & RHEUMATOLOGY | 2019年 / 71卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0280
引用
收藏
页数：2
相关论文
共 50 条
  • [41] SUSTAINED EFFECTIVENESS OF METHOTREXATE WITH STEP-DOWN GLUCOCORTICOID REMISSION INDUCTION (COBRA SLIM) FOR EARLY RHEUMATOID ARTHRITIS IN A TREAT-TO- TARGET SETTING: 2-YEAR RESULTS OF THE CARERA TRIAL
    Stouten, V.
    Joly, J.
    De Cock, D.
    Pazmino, S.
    Van der Elst, K.
    Westhovens, R.
    Verschueren, P.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 147 - 147
  • [42] A treat-to-target strategy with methotrexate and intra-articular triamcinolone with or without adalimumab effectively reduces MRI synovitis, osteitis and tenosynovitis and halts structural damage progression in early rheumatoid arthritis: results from the OPERA randomised controlled trial
    Axelsen, Mette Bjorndal
    Eshed, Iris
    Horsley-Petersen, Kim
    Stengaard-Pedersen, Kristian
    Hetland, Merete Lund
    Moller, Jakob
    Junker, Peter
    Podenphant, Jan
    Schlemmer, Annette
    Ellingsen, Torkell
    Ahlquist, Palle
    Lindegaard, Hanne
    Linauskas, Asta
    Dam, Mette Yde
    Hansen, Ib
    Horn, Hans Christian
    Ammitzboll, Christian Gytz
    Jorgensen, Anette
    Krintel, Sophine B.
    Raun, Johnny
    Krogh, Niels S.
    Johansen, Julia Sidenius
    Ostergaard, Mikkel
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 (05) : 867 - 875
  • [43] Long Term Efficacy of a 2-year MRI Treat-to-target Treatment Strategy on Disease Activity, MRI Inflammation and Physical Function in Rheumatoid Arthritis Patients in Clinical Remission: Five Year Follow-up of the IMAGINE-RA Cohort
    Moller-Bisgaard, Signe
    Horslev-Petersen, Kim
    Glinatsi, Daniel
    Ejbjerg, Bo
    Hetland, Merete Lund
    Moller, Jakob Mollenbach
    Christensen, Robin
    Nielsen, Sabrina Mai
    Boesen, Mikael
    Stengaard-Pedersen, Kristian
    Madsen, Ole Rintek
    Jensen, Bente
    Villadsen, Jan Alexander
    Hauge, Ellen Margrethe
    Hendricks, Oliver
    Lindegaard, Hanne Merete
    Krogh, Niels Steen
    Jurik, Anne Grethe
    Thomsen, Henrik
    Ostergaard, Mikkel
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 1758 - 1760
  • [44] Sustained inhibition of progressive joint damage with rituximab plus methotrexate in early active rheumatoid arthritis: 2-year results from the randomised controlled trial IMAGE
    Tak, Paul P.
    Rigby, William
    Rubbert-Roth, Andrea
    Peterfy, Charles
    van Vollenhoven, Ronald F.
    Stohl, William
    Healy, Emma
    Hessey, Eva
    Reynard, Mark
    Shaw, Tim
    ANNALS OF THE RHEUMATIC DISEASES, 2012, 71 (03) : 351 - 357
  • [45] MRI bone oedema is the strongest predictor of subsequent radiographic progression in early rheumatoid arthritis. Results from a 2-year randomised controlled trial (CIMESTRA)
    Hetland, M. L.
    Ejbjerg, B.
    Horslev-Petersen, K.
    Jacobsen, S.
    Vestergaard, A.
    Jurik, A. G.
    Stengaard-Pedersen, K.
    Junker, P.
    Lottenburger, T.
    Hansen, I.
    Andersen, L. S.
    Tarp, U.
    Skjodt, H.
    Pedersen, J. K.
    Majgaard, O.
    Svendsen, A. J.
    Ellingsen, T.
    Lindegaard, H.
    Christensen, A. F.
    Vallo, J.
    Torfing, T.
    Narvestad, E.
    Thomsen, H. S.
    Ostergaard, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2009, 68 (03) : 384 - 390
  • [46] Tocilizumab Combination Therapy or Monotherapy or Methotrexate Monotherapy in Methotrexate-Naive Patients with Early Rheumatoid Arthritis: 2-Year Clinical and Radiographic Results from a Randomized, Placebo-Controlled Trial.
    Burmester, Gerd
    Rigby, William
    van Vollenhoven, Ronald F.
    Kay, Jonathan
    Rubbert-Roth, Andrea
    Blanco, Ricardo
    Kelman, Ariella
    Dimonaco, Sophie
    Mitchell, Nina
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S811 - S812
  • [47] Effectiveness of methotrexate with step-down glucocorticoid remission induction ( COBRA Slim) versus other intensive treatment strategies for early rheumatoid arthritis in a treat-to-target approach: 1-year results of CareRA, a randomised pragmatic open-label superiority trial
    Verschueren, Patrick
    De Cock, Diederik
    Corluy, Luk
    Joos, Rik
    Langenaken, Christine
    Taelman, Veerle
    Raeman, Frank
    Ravelingien, Isabelle
    Vandevyvere, Klaas
    Lenaerts, Jan
    Geens, Elke
    Geusens, Piet
    Vanhoof, Johan
    Durnez, Anne
    Remans, Jan
    Vander Cruyssen, Bert
    Van Essche, Els
    Sileghem, An
    De Brabanter, Griet
    Joly, Johan
    Meyfroidt, Sabrina
    Van der Elst, Kristien
    Westhovens, Rene
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 (03) : 511 - 520
  • [48] Physical function and health related quality of life: Analysis of 2-year data from randomized, controlled studies of leflunomide, sulfasalazine, or methotrexate in patients with active rheumatoid arthritis
    Strand, V
    Scott, DL
    Emery, P
    Kalden, JR
    Smolen, JS
    Cannon, GW
    Tugwell, P
    Crawford, B
    JOURNAL OF RHEUMATOLOGY, 2005, 32 (04) : 590 - 601
  • [49] EFFECTS OF ADALIMUMAB ADDED TO TREAT-TO-TARGET STRATEGY WITH METHOTREXATE AND INTRA-ARTICULAR TRIAMCINOLONE ON LIPIDS IN EARLY- AND TREATMENT NAIVE RHEUMATOID PATIENTS: SECONDARY ANALYSES FROM THE MULTICENTER DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED OPERA TRIAL
    Masic, D.
    Stengaard-Pedersen, K.
    Logstrup, B. B.
    Horslev-Petersen, K.
    Hetland, M. L.
    Junker, P.
    Ostergaard, M.
    Ammitzbol, C.
    Moller, S.
    Christensen, R.
    Ellingsen, T.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 607 - 607
  • [50] Soy isoflavones decrease fibroglandular breast tissue measured by magnetic resonance imaging in premenopausal women: A 2-year randomized double-blind placebo controlled clinical trial
    Lu, Lee-Jane W.
    Chen, Nai-Wei
    Brunder, Donald G.
    Nayeem, Fatima
    Nagamani, Manubai
    Nishino, Thomas K.
    Anderson, Karl E.
    Khamapirad, Tuenchit
    CLINICAL NUTRITION ESPEN, 2022, 52 : 158 - 168
12345